Skip to content

Synapse Biomedical, Inc.

Active in EUDAMED

United Statesfrom SRN EUDAMED SRN US-MF-000029893

Synapse Biomedical, Inc. is a medical device manufacturer based in the United States, with 72 devices listed in 4 registries (FDA Class III and II; EU Class IIa) and 2 FDA recalls as of 19 Nov 2026.

Devices
72
Registrations
EUDAMED
FDA recalls
2

Registry facts

Counted by deviCERTS from registry records, 19 Nov 2026

Registries
  • FDA GUDID 69
  • EUDAMED 2
  • FDA 510(k) 1
  • FDA PMA 1

A device listed in two registries counts in both.

Device classes
  • FDA Class III 54
  • FDA Class II 16
  • EU Class IIa 1
Identifiers
  • EUDAMED SRN US-MF-000029893
  • DUNS 138432070

At a glance

Counted by deviCERTS from registry records

EU certificates

1 of 1 in force.

See certificates

Market reach

European Union
EUDAMED actor, 1 certificate
United States
FDA recalls

What Synapse Biomedical, Inc. makes

Synapse Biomedical, Inc. makes intramuscular diaphragm/phrenic nerve electrical stimulation systems, including external pulse generators, percutaneous stimulation leads, programmers, and active and return electrodes for these systems. Example devices include the NeuRx DPS™ External Pulse Generator, NeuRx DPS™ System Kit, Active Sensor Module, and related accessories such as sterile lead tunnelers, disposable electrode delivery tools, extended-life batteries, silicone adhesive kits, surface electrodes, and connector holder kits.

The company's devices are classified as Class II and Class III and are listed in the FDA 510(k), FDA PMA, and FDA UDI registries. Synapse Biomedical, Inc. is based in the United States.

AI-generated from registry data, 26 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue72

Newest first, rows 1-50 of 72

Search and filter all 72 devices
Skip device list

Rows 1-50 of 72

Showing 1-50 of 72

Company details

EUDAMED record synced 7 Nov 2026

EUDAMED SRN
US-MF-000029893
DUNS number
138432070
EUDAMED status
Active
EUDAMED registered name
Synapse Biomedical, Inc.
EUDAMED abbreviated name
Synapse Biomedical
Registered address
300, Artino Street, 44074, Oberlin, OH, United States
Phone
+1 440 774 2488 x137
PRRC contact
Jason Fiest(public in EUDAMED)

EUDAMED certificates1

1 certificate1 valid, 0 expiredMDR 1next expiry 31 Mar 2031

EUDAMED certificates (1)

BSI Group The Netherlands B.V. 2797 1 certificate

  • MDR 791578 Active

    Quality management system EU MDR

    Issued
    1 Apr 2026
    Expires
    31 Mar 2031

FDA recalls2

Recalls are matched to the firm by name. FDA recall data as of 1 Nov 2026.

FDA recall records list 2 recalls initiated by Synapse Biomedical, Inc., the earliest on 2022-05-31 and the most recent on 2022-07-11. By recorded status: 2 terminated. The reasons filed fall into these groups: labeling or instructions for use, packaging and performance or accuracy. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.

Generated automatically from FDA recall records, as a summary of the records listed below. It describes what the records state and is not an assessment of this manufacturer.

Recalls initiated per year

  • 2017 0
  • 2018 0
  • 2019 0
  • 2020 0
  • 2021 0
  • 2022 2
  • 2023 0
  • 2024 0
  • 2025 0
  • 2026 0
  • 2022

    • 11 Jul 2022 Z-1561-2022 Class I Terminated Due to a defect identified on the EPG controller printed circuit board assembly, device performance may degrade over time. Depending on the failure mode, potential adverse events include pain, muscle fatigue and decreased breathing effectiveness, arrhythmia or cardiac arrest, or the device may stop unexpectedly. Distribution: distribution to US states of AL, CO, IL, FL, GA, MD, MN, NC, NJ, OH, PA, and SC; Germany and Kuwait. ***Updated 3/28/23…
      Full distribution text distribution to US states of AL, CO, IL, FL, GA, MD, MN, NC, NJ, OH, PA, and SC; Germany and Kuwait. ***Updated 3/28/23 - Product was not distributed to United Arab Emirates. Product was distributed to Kuwait.*** Updated 9.14.23 - 1 patient in Germany, 1 patient in the Czech Republic, 1 distributor in Kuwait
    • 31 May 2022 Z-1393-2022 Class III Terminated Firm has revised labeling to consistently call out storage conditions and revised the instructions for use to clarify that the temperature range symbol is intended to indicate storage conditions (versus transport conditions or tolerance conditions for the package material). Distribution: Domestic distribution to AL CA CO FL GA IL MA MI MN NC NJ NY OH OK OR PA SC TX WV. Foreign distribution pending.

From the company website

Read 18 Sep 2026

NOCI envisions a future where effective use of outcome assessments drives the development of novel spinal care treatments. By collaborating with the Spinal Cord Injury (SCI) community, NOCI implements clinical discoveries that lead to impactful solutions and improved patient outcomes. Their services include customized clinical research, outcome measure development, training for healthcare professionals, and independent medical evaluations. As Synapse’s exclusive partner in Canada, NOCI is dedicated to promoting advanced respiratory care and delivering innovative solutions that enhance patient outcomes.

From the manufacturer's own website. Source

Frequently asked questions

How many devices does Synapse Biomedical, Inc. have in the registry?

The registry currently lists 72 devices for Synapse Biomedical, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Synapse Biomedical, Inc.'s devices?

Among its 50 most recently registered devices, Synapse Biomedical, Inc. has devices listed in EUDAMED (1 device) and FDA GUDID (49 devices). A device can be listed in more than one registry, so these counts overlap.

What risk classes do Synapse Biomedical, Inc.'s devices fall under?

Among its 50 most recently registered devices, the classes recorded for Synapse Biomedical, Inc.'s devices are Class IIa, Class II and Class III. Each device page shows its own class and authorisation.

Are there FDA recall records for Synapse Biomedical, Inc.?

FDA recall records list 2 recalls initiated by Synapse Biomedical, Inc., the most recent initiated on 11 Jul 2022. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.

What EUDAMED certificates are recorded for Synapse Biomedical, Inc.?

EUDAMED lists 1 certificate for Synapse Biomedical, Inc. (quality management system) under MDR. 1 is recorded with the status issued. The most recent was issued on 1 Apr 2026.

What are the newest devices from Synapse Biomedical, Inc. in the registry?

The most recently registered devices listed for Synapse Biomedical, Inc. include TransAeris System, Clinical Kit, Synchrony 20-3001, Stimulator, Synchony 23-3000 and Sensor, Synchony 23-3001.

Generated automatically from registry data and not verified by a human reviewer.